Skip to main content

sec filings

Insider trades

Open-market buys and sales that company insiders report to the SEC on .

Side
Planned sales
Role
IPSC

Updated 10/6/2026, 1:28 PM ET.

IPSC

Century Therapeutics, Inc.

Sale$4,993

Russotti Gregory

See Remarks

2,587 shat $1.93Filed Sep 15, 6:25 PM ETFiling
IPSC

Century Therapeutics, Inc.

Sale$3,200

Carr Douglas

SVP Finance & Operations

1,658 shat $1.93Filed Sep 15, 6:25 PM ETFiling
IPSC

Century Therapeutics, Inc.

Sale$1,095

Russotti Gregory

See Remarks

534 shat $2.05Filed Sep 9, 4:35 PM ETFiling
IPSC

Century Therapeutics, Inc.

Sale$521

Carr Douglas

SVP Finance & Operations

254 shat $2.05Filed Sep 9, 4:34 PM ETFiling
IPSC

Century Therapeutics, Inc.

Sale$544

Carr Douglas

SVP Finance & Operations

275 shat $1.98Filed Aug 5, 4:08 PM ETFiling

Read from public SEC filings. Not financial advice.